# Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males

> **NCT01375387** · PHASE1 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 33 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Lacosamide
- **DRUG:** Lacosamide
- **DRUG:** Lacosamide
- **OTHER:** Placebo 3
- **OTHER:** Placebo 4
- **OTHER:** Placebo 2

## Key facts

- **NCT ID:** NCT01375387
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2011-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01375387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01375387, "Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01375387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*